Louis P Lacasse - Net Worth and Insider Trading

Louis P Lacasse Net Worth

The estimated net worth of Louis P Lacasse is at least $453,537 dollars as of 2024-09-14. Louis P Lacasse is the Director of Conatus Pharmaceuticals Inc and owns about 809,887 shares of Conatus Pharmaceuticals Inc (CNAT) stock worth over $453,537. Details can be seen in Louis P Lacasse's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Louis P Lacasse has not made any transactions after 2013-07-30 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Louis P Lacasse

To

Louis P Lacasse Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Louis P Lacasse owns 2 companies in total, including Histogen Inc (HSTO) , and Armata Pharmaceuticals Inc (ARMP) .

Click here to see the complete history of Louis P Lacasse’s form 4 insider trades.

Insider Ownership Summary of Louis P Lacasse

Ticker Comapny Transaction Date Type of Owner
HSTO Histogen Inc 2013-07-24 director
ARMP Armata Pharmaceuticals Inc 2004-05-20 director

Louis P Lacasse Latest Holdings Summary

Louis P Lacasse currently owns a total of 1 stock. Louis P Lacasse owns 809,887 shares of Conatus Pharmaceuticals Inc (CNAT) as of July 30, 2013, with a value of $453,537.

Latest Holdings of Louis P Lacasse

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
CNAT Conatus Pharmaceuticals Inc 2013-07-30 809,887 0.56 453,537

Holding Weightings of Louis P Lacasse


Louis P Lacasse Form 4 Trading Tracker

According to the SEC Form 4 filings, Louis P Lacasse has made a total of 0 transactions in Conatus Pharmaceuticals Inc (CNAT) over the past 5 years. The most-recent trade in Conatus Pharmaceuticals Inc is the acquisition of 123,950 shares on July 30, 2013, which cost Louis P Lacasse around $1 Million.

Insider Trading History of Louis P Lacasse

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Louis P Lacasse Trading Performance

GuruFocus tracks the stock performance after each of Louis P Lacasse's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Louis P Lacasse is -2.19%. GuruFocus also compares Louis P Lacasse's trading performance to market benchmark return within the same time period. The performance of stocks bought by Louis P Lacasse within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Louis P Lacasse's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Louis P Lacasse

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
0 out of 1 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) -0.66 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) 2.48 LIMIT LIMIT LIMIT LIMIT LIMIT

Louis P Lacasse Ownership Network

Ownership Network List of Louis P Lacasse

No Data

Ownership Network Relation of Louis P Lacasse

Insider Network Chart

Louis P Lacasse Owned Company Details

What does Histogen Inc do?

Who are the key executives at Histogen Inc?

Louis P Lacasse is the director of Histogen Inc. Other key executives at Histogen Inc include See Remarks Joyce Reyes , director & See Remarks Richard W Pascoe , and See Remarks Moya Daniels .

Histogen Inc (HSTO) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Histogen Inc (HSTO) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Histogen Inc (HSTO) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Histogen Inc (HSTO)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Histogen Inc Insider Transactions

No Available Data

Louis P Lacasse Mailing Address

Above is the net worth, insider trading, and ownership report for Louis P Lacasse. You might contact Louis P Lacasse via mailing address: Targeted Genetics Corp, 1100 Olive Way Ste 100, Seattle Wa 98101.

Discussions on Louis P Lacasse

No discussions yet.